Concepedia

Taylor Dismuke

TD

5

Publications

234

Citations

5

H-Index

2019

Active since

Affiliations

University of North Carolina at Chapel Hill(Current)

Children's Hospital Colorado

Wellcome Sanger Institute

University of Colorado Anschutz Medical Campus

Morgan Adams Foundation

Taylor Dismuke is an author at University of North Carolina at Chapel Hill.

Publications per year

2019–2025

5

Publications

5

scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapy

Jennifer K. Ocasio, Benjamin Babcock, Daniel Malawsky et al. · Nature Communications · 2019 · 107 citations · Full text

Poly(2-oxazoline) nanoparticle delivery enhances the therapeutic potential of vismodegib for medulloblastoma by improving CNS pharmacokinetics and reducing systemic toxicity

Duhyeong Hwang, Taylor Dismuke, Andrey P. Tikunov et al. · Nanomedicine Nanotechnology Biology and Medicine · 2020 · 55 citations · Full text

Enhancing CDK4/6 inhibitor therapy for medulloblastoma using nanoparticle delivery and scRNA-seq–guided combination with sapanisertib

Chaemin Lim, Taylor Dismuke, Daniel Malawsky et al. · Science Advances · 2022 · 41 citations · Full text

Cryptic developmental events determine medulloblastoma radiosensitivity and cellular heterogeneity without altering transcriptomic profile

Daniel Malawsky, Seth Weir, Jennifer K. Ocasio et al. · Communications Biology · 2021 · 19 citations · Full text

Suppressing recurrence in Sonic Hedgehog subgroup medulloblastoma using the OLIG2 inhibitor CT-179

Yuchen Li, Chaemin Lim, Taylor Dismuke et al. · Nature Communications · 2025 · 12 citations · Full text

Rows per page

1–5 of 5